+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Subcutaneous Insulin Infusion Market by Product, Patient Type, End-user - Global Forecast 2025-2030- Product Image
Continuous Subcutaneous Insulin Infusion Market by Product, Patient Type, End-user - Global Forecast 2025-2030- Product Image
Sale

Continuous Subcutaneous Insulin Infusion Market by Product, Patient Type, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337448
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Continuous Subcutaneous Insulin Infusion Market grew from USD 2.72 billion in 2023 to USD 3.05 billion in 2024. It is expected to continue growing at a CAGR of 12.16%, reaching USD 6.08 billion by 2030.

Continuous Subcutaneous Insulin Infusion (CSII) is a method of delivering insulin through a small device, typically known as an insulin pump, to manage diabetes effectively. This approach is increasingly favored over traditional injection methods due to its ability to mimic the body's natural insulin patterns more closely. The application of CSII is particularly essential for individuals with Type 1 diabetes, although certain Type 2 patients also benefit. The end-use scope encompasses hospitals, clinics, and home healthcare settings, with the technology facilitating better blood glucose control and improving quality of life. Market growth is primarily influenced by the rising prevalence of diabetes, advancements in technology such as artificial intelligence integration, and a growing preference for minimally invasive and tailored treatment options. Key potential opportunities lie in expanding market penetration in emerging economies, where diabetes prevalence is high but CSII adoption remains low. Companies could focus on reducing device costs and enhancing user-friendliness to seize such opportunities. However, the market faces several limitations, including high costs, limited awareness in developing regions, and complications such as skin infections associated with device use. Regulatory challenges and high R&D costs are also notable barriers. To drive innovation, companies could invest in the development of smart pumps with integrated continuous glucose monitoring (CGM) systems and explore partnerships with tech firms to enhance data analytics capabilities. The market is characterized by rapid technological advancements and a shift towards personalized medicine, presenting substantial opportunities for companies willing to adapt swiftly. For sustained growth, businesses should focus on educating both healthcare professionals and patients on the advantages of CSII, actively address any potential adverse effects, and strive for improvements in product efficacy and affordability.

Understanding Market Dynamics in the Continuous Subcutaneous Insulin Infusion Market

The Continuous Subcutaneous Insulin Infusion Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising number of diabetes patients across the world
    • Growing awareness of advanced insulin delivery devices
    • Rising healthcare expenditure pertinent to diabetes globally
  • Market Restraints
    • High cost of devices
  • Market Opportunities
    • Emerging technological advancements such as AI and IoT
    • Ongoing rise in the number of product launches by market players
  • Market Challenges
    • Possible risks such as diabetic ketoacidosis and hypoglycemia

Exploring Porter’s Five Forces for the Continuous Subcutaneous Insulin Infusion Market

Porter’s Five Forces framework further strengthens the insights of the Continuous Subcutaneous Insulin Infusion Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Continuous Subcutaneous Insulin Infusion Market

External macro-environmental factors deeply influence the performance of the Continuous Subcutaneous Insulin Infusion Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Continuous Subcutaneous Insulin Infusion Market

The Continuous Subcutaneous Insulin Infusion Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Continuous Subcutaneous Insulin Infusion Market

The Continuous Subcutaneous Insulin Infusion Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Continuous Subcutaneous Insulin Infusion Market

The Continuous Subcutaneous Insulin Infusion Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Continuous Subcutaneous Insulin Infusion Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Bigfoot Biomedical, Inc., CeQur Corporation, Fresenius SE & Co. KGaA, MannKind Corporation, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Sanofi S.A., Shinmyung Mediyes CO., LTD., Smiths Group PLC, SOOIL Developments Co., Ltd., Tandem Diabetes Care, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Continuous Subcutaneous Insulin Infusion Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Patch Pumps
      • Basal
      • Basal & Bolus
      • Bous
    • Tethered Pumps
      • Battery
      • Insulin Reservoir & Cartridges
      • Insulin Set Insertion Devices
  • Patient Type
    • Type 1 Diabetes
    • Type 2 Diabetes
  • End-user
    • Homecare
    • Hospitals
    • Laboratory
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of diabetes patients across the world
5.1.1.2. Growing awareness of advanced insulin delivery devices
5.1.1.3. Rising healthcare expenditure pertinent to diabetes globally
5.1.2. Restraints
5.1.2.1. High cost of devices
5.1.3. Opportunities
5.1.3.1. Emerging technological advancements such as AI and IoT
5.1.3.2. Ongoing rise in the number of product launches by market players
5.1.4. Challenges
5.1.4.1. Possible risks such as diabetic ketoacidosis and hypoglycemia
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Continuous Subcutaneous Insulin Infusion Market, by Product
6.1. Introduction
6.2. Patch Pumps
6.2.1. Basal
6.2.2. Basal & Bolus
6.2.3. Bous
6.3. Tethered Pumps
6.3.1. Battery
6.3.2. Insulin Reservoir & Cartridges
6.3.3. Insulin Set Insertion Devices
7. Continuous Subcutaneous Insulin Infusion Market, by Patient Type
7.1. Introduction
7.2. Type 1 Diabetes
7.3. Type 2 Diabetes
8. Continuous Subcutaneous Insulin Infusion Market, by End-user
8.1. Introduction
8.2. Homecare
8.3. Hospitals
8.4. Laboratory
9. Americas Continuous Subcutaneous Insulin Infusion Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Continuous Subcutaneous Insulin Infusion Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Continuous Subcutaneous Insulin Infusion Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET RESEARCH PROCESS
FIGURE 2. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET DYNAMICS
TABLE 7. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL & BOLUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR & CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 43. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 44. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 70. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 71. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 75. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 76. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 161. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 162. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 181. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 182. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 186. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 187. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Continuous Subcutaneous Insulin Infusion Market, which are profiled in this report, include:
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bigfoot Biomedical, Inc.
  • CeQur Corporation
  • Fresenius SE & Co. KGaA
  • MannKind Corporation
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Sanofi S.A.
  • Shinmyung Mediyes CO., LTD.
  • Smiths Group PLC
  • SOOIL Developments Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Ypsomed AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.08 Billion
Compound Annual Growth Rate12.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Insulin Infusion Pumps - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 100 Pages
  • Global
From
Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 216 Pages
  • Global
From
Insulin Patch Pumps Global Market Report 2024 - Product Image

Insulin Patch Pumps Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Insulin Pumps - Global Strategic Business Report - Product Image

Insulin Pumps - Global Strategic Business Report

  • Report
  • 258 Pages
  • Global
From
Insulin Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Insulin Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.